Indivior Pharmaceuticals, Inc. (INDV)
32.27
+0.22
(+0.69%)
USD |
NASDAQ |
Mar 06, 16:00
32.28
+0.02
(+0.05%)
Pre-Market: 20:00
Indivior Pharmaceuticals Free Cash Flow : -94.86M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CorMedix, Inc. | 172.79M |
| Amicus Therapeutics, Inc. | 29.85M |
| Apyx Medical Corp. | -9.503M |
| Nephros, Inc. | 2.719M |
| Owlet, Inc. | -10.80M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -226.38M |
| Cash from Investing (Quarterly) | -22.46M |
| Cash from Financing (Quarterly) | -5.638M |
| Free Cash Flow Per Share (Quarterly) | -1.999 |
| Free Cash Flow to Equity (Quarterly) | -244.85M |
| Free Cash Flow to Firm (Quarterly) | -242.29M |
| Free Cash Flow Yield | -2.33% |